Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab

We read with interest the article by Kearney and coworkers in the Journal that reported on the emulation of a hypothetical trial comparing mepolizumab, benralizumab, and dupilumab in the treatment of uncontrolled asthma.

Authors

Corinne Keet (ORCID: https://orcid.org/0000-0002-6585-239X)
Ayobami Akenroye (ORCID: https://orcid.org/0000-0002-1909-1470)

Institutions

University of North Carolina at Chapel Hill (US)

Publication Details

Journal: UNC Libraries
Published: 2024-09-28
DOI: https://doi.org/10.17615/jefg-vc06
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab

Corinne Keet, Ayobami Akenroye

Sep 28, 2024

UNC Libraries

Cancer Immunotherapy and Biomarkers

article

Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab

Corinne Keet, Ayobami Akenroye

September 28, 2024article en

Abstract

UNC Libraries

University of North Carolina at Chapel Hill (US)

Zero hunger

Openalex Percentile: Top 70%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab — Corinne Keet, Ayobami Akenroye · UNC Libraries (2024) | TGRS Research Map | TGRS